- Products
- Catalogs
- News & Trends
- Exhibitions
Rapid myocardial infarction test MyoCheck®for atherosclerosissPLA2-IIAserum
Add to favorites
Compare this product
Characteristics
- Applications
- for myocardial infarction, for atherosclerosis
- Tested parameter
- sPLA2-IIA
- Sample type
- serum, plasma
- Analysis mode
- immunochromatographic
- Result display time
10 min
- Sample volume
0.025 ml
(0.00085 US fl oz)
Description
Extensive studies
Meaningful
To measure the effectiveness of therapeutic interventions
Product description
Rapid test for the assessment of cardiovascular risk
MyoCheck® sPLA2-IIA is a quantitative rapid test for identifying and monitoring cardiovascular risk patients. It detects soluble phospholipase A2-IIA, an enzyme that is elevated in patients at risk for myocardial infarction or stroke. The marker is independent of other risk factors. This makes the test particularly suitable for identifying apparently healthy individuals at high cardiovascular risk.
Technical details
Format quantitative immunochromatographic in vitro test
Measuring range 20-500 ng/ml
Number of pieces 20
Storage temperature 2-30 °C
Related Searches
- Assay kit
- Blood assay kit
- Immunoassay assay kit
- Plasma assay kit
- Blood rapid diagnostic test
- Rapid lateral flow test
- Immunoassay rapid diagnostic test
- Rapid virus test
- Serum rapid diagnostic test
- Plasma rapid diagnostic test
- Whole blood rapid diagnostic test
- Lateral flow test kit
- Infectious disease rapid diagnostic test
- Rapid respiratory infection test
- Urine rapid diagnostic test
- COVID-19 rapid diagnostic test
- Laboratory rapid diagnostic test
- Rapid cardiovascular disease test
- Tumour detection rapid test
- Fertility rapid diagnostic test
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.